Equity
€78,033 from €245,789 in 2023
Equity fell by 68% in 2 years.
OCULES
Lifetime
5 annual accounts with figures on one time axispeak €413,742 (2023)
€235,167▲ 8.4%
lowest -€11,239 (2021)
-€8,551▼ €9,347
peak €245,789 (2023)
€78,033▼ 9.9%
€454,548▼ 16.2%
peak 2 FTE (2024)
2 FTEunchanged
Board2 names since 2021
2 directors and 1 other
Documentsfilings and deeds
22-06-202639 days before the deadline
2025abbreviated format
Loss of €8,551Debts from €542,606 to €454,548Cash from €8,326 to €18,280
Key points
from the 2025 annual accountsTurnover
≈ €440,000 estimated
The accounts state no turnover.
Debts
€454,548 85% of the balance sheet
Financial debts 74%Taxes and wages 3%Other 23%
Of this, €116,531 falls due within a year.
Investments
€8,500 0.1 × depreciation
Green is investment, beige is depreciation.
Filings
5 annual accounts since 2021
The last five annual accounts were filed 0 to 39 days before the end of the period.
Position in the sector
-€8,551
Lower net result than 91% of companies in human health. Sector median €125,403 · 2,765 companies.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 1,547 companies had the same profile as OCULES has now. Each dot stands for 4 companies, two years later.
91.3%
were still trading
3.9%
stopped another way
4.3%
went bankrupt
Another 0.5% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 1,547 companies, not a prediction for OCULES. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Board and ownership
Director
Director
- 60 sharesdeed of 23-08-2021
- 60 sharesdeed of 23-08-2021
Recent changes
Incorporation
Founding capital of €5,000, 120 shares · Founders: and · Appointments: (director) and (director) · published on 23-08-2021 · Gazette deed
First establishment
Kamiel Dekelverstraat 5, Bekkevoort
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| OCULES Bekkevoort | €532,581 | €235,167 | 14.7% | 2 |
| Oogcentrum Westkust Koksijde | €471,860 | €245,315 | -13.8% | 1.7 |
| SOCIETE MEDICALE L. JADOT Chaudfontaine | €510,284 | €315,692 | 25.9% | 1 |
| DOCTEUR ANNE DECKERS Dalhem | €534,561 | €187,068 | 75.1% | 1 |
| UBP Imaging Waterloo | €829,540 | €190,261 | -3.4% | 2.4 |
| Oogcentrum Lommel Lommel | €446,950 | €142,023 | 22.0% | 1.7 |
| Clinique de la Vision Charleroi Charleroi | €856,516 | €369,456 | 29.7% | 1.9 |
These companies have the same main activity as OCULES: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €447,000 and €857,000, founded between 2019 and 2024.
Official details
Source: KBO- Status
- Active since 19-08-2021Normal situation
- Activity
- Specialist medical practiceNACE 86220and 1 other
- Joint committee
- 330.04Health institutions and services · annual accounts 2025
- Establishment unit
- 2.321.381.1353460 Bekkevoort, since 19-08-2021
- Financial year end
- 31 December
- Peppol
- Reachable
Annual accounts 2025
- €532,581▼ 15.4%
- Employeeson 31-12-2025
- 2=
- Filing
- Filed on 22-06-2026, 39 days before the end of the filing period
Insights on OCULES
OCULES files the abbreviated format. That format states no turnover. The gross margin rose from -€8,146 in 2021 to €235,167 in 2025.
The balance sheet grew most from 2022 to 2023 through fixed assets, financed with long-term debt.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about OCULES
- What is the company number of OCULES?
- The company number of OCULES is 0772.666.960. The VAT number is the same number with BE in front: BE 0772.666.960.
- Where is OCULES based?
- The registered office is at Kamiel Dekelverstraat 5, 3460 Bekkevoort.Company details
- What does OCULES do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of OCULES?
- OCULES is a private limited company (BV).
- When was OCULES founded?
- OCULES was founded on 19-08-2021.
- Is OCULES still active?
- Yes, OCULES is an active enterprise in the KBO register.
- How many employees does OCULES have?
- OCULES had an average of 2 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does OCULES fall under?
- In its 2025 annual accounts, OCULES states joint committee 330.04 (Health institutions and services).
- What is the turnover of OCULES?
- The turnover in financial year 2025 is ≈ €440,000. This figure is estimated from the gross margin of €235,167 and 41 comparable companies (NACE 86220). It probably lies between €370,000 and €580,000.
- Is OCULES profitable?
- In financial year 2025, OCULES made a loss of €8,551.
- Where can I find the annual accounts of OCULES?
- OCULES filed 5 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of OCULES due?
- OCULES must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check See which support similar companies received that this one did not.Subsidies Compare this company with its sector.Sector benchmark
See how customers, suppliers and banks see your own company and what to improve first.